AGIO - Agios Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.25B
Enterprise Value 32.58B
Trailing P/E N/A
Forward P/E 1-9.51
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)43.84
Price/Book (mrq)4.28
Enterprise Value/Revenue 334.81
Enterprise Value/EBITDA 6-7.39

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-480.30%

Management Effectiveness

Return on Assets (ttm)-27.55%
Return on Equity (ttm)-56.61%

Income Statement

Revenue (ttm)74.17M
Revenue Per Share (ttm)1.35
Quarterly Revenue Growth (yoy)33.80%
Gross Profit (ttm)-249.67M
EBITDA -349.34M
Net Income Avi to Common (ttm)-342.52M
Diluted EPS (ttm)-6.22
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)669.89M
Total Cash Per Share (mrq)11.51
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.21
Book Value Per Share (mrq)13.07

Cash Flow Statement

Operating Cash Flow (ttm)-304.69M
Levered Free Cash Flow (ttm)-163.74M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.74
52-Week Change 3-28.26%
S&P500 52-Week Change 3-6.95%
52 Week High 399.82
52 Week Low 341.63
50-Day Moving Average 351.18
200-Day Moving Average 369.15

Share Statistics

Avg Vol (3 month) 3626.02k
Avg Vol (10 day) 3641.78k
Shares Outstanding 558.18M
Float 50.91M
% Held by Insiders 112.91%
% Held by Institutions 198.26%
Shares Short (Dec 31, 2018) 47M
Short Ratio (Dec 31, 2018) 49.64
Short % of Float (Dec 31, 2018) 424.08%
Short % of Shares Outstanding (Dec 31, 2018) 412.02%
Shares Short (prior month Nov 30, 2018) 46.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A